An inflammatory bowel disease-associated SNP increases local thyroglobulin expression to develop inflammation in miniature dachshunds

Front Vet Sci. 2023 Jul 14:10:1192888. doi: 10.3389/fvets.2023.1192888. eCollection 2023.

Abstract

Inflammatory colorectal polyp (ICRP) in miniature dachshunds (MDs) is a chronic inflammatory bowel disease (IBD) characterized by granulomatous inflammation that consists of neutrophil infiltration and goblet cell hyperplasia in the colon. Recently, we identified five MD-associated single-nucleotide polymorphisms (SNPs), namely PLG, TCOF1, TG, COL9A2, and COL4A4, by whole-exome sequencing. Here, we investigated whether TG c.4567C>T (p.R1523W) is associated with the ICRP pathology. We found that the frequency of the T/T SNP risk allele was significantly increased in MDs with ICRP. In vitro experiments showed that TG expression in non-immune cells was increased by inducing the IL-6 amplifier with IL-6 and TNF-α. On the other hand, a deficiency of TG suppressed the IL-6 amplifier. Moreover, recombinant TG treatment enhanced the activation of the IL-6 amplifier, suggesting that TG is both a positive regulator and a target of the IL-6 amplifier. We also found that TG expression together with two NF-κB targets, IL6 and CCL2, was increased in colon samples isolated from MDs with the T/T risk allele compared to those with the C/C non-risk allele, but serum TG was not increased. Cumulatively, these results suggest that the T/T SNP is an expression quantitative trait locus (eQTL) of TG mRNA in the colon, and local TG expression triggered by this SNP increases the risk of ICRP in MDs via the IL-6 amplifier. Therefore, TG c.4567C>T is a diagnostic target for ICRP in MDs, and TG-mediated IL-6 amplifier activation in the colon is a possible therapeutic target for ICRP.

Keywords: IL-6 amplifier; SNP; canine; inflammation; inflammatory colorectal polyps; miniature dachshund; thyroglobulin.

Grants and funding

This study was supported by JSPS KAKENHI (MT and MM), AMED Grant Numbers JP21zf0127004 and JP22zf0127004 (MM), the Joint Usage/Research Center Institute for Genetic Medicine, Hokkaido University (MM), the Photo-excitonix Project, MEXT Quantum Leap Flagship Program (MEXT Q-LEAP) Grant Number JPMXS0120330644, and the Project of Young Investigator Promotion at Hokkaido University (MM).